CBFB-MYH11 Inv(16) Qualitative Test
Introduction
The CBFB-MYH11 Inv(16) Qualitative test is a vital diagnostic tool used to detect specific genetic abnormalities associated with hematological disorders, particularly acute myeloid leukemia (AML). This test identifies the presence of the CBFB-MYH11 fusion gene, which is crucial for determining the appropriate treatment plan for affected patients. Understanding genetic markers can significantly influence patient outcomes, making this test an essential part of modern diagnostics.
What the Test Measures
This qualitative test specifically measures the presence of the CBFB-MYH11 fusion gene resulting from the inversion of chromosome 16. The detection of this gene fusion is critical in diagnosing certain types of leukemia, allowing healthcare providers to tailor treatment strategies effectively.
Who Should Consider This Test?
Individuals who may need to consider the CBFB-MYH11 Inv(16) Qualitative test include:
- Patients exhibiting symptoms of acute myeloid leukemia (AML), such as fatigue, fever, and easy bruising.
- Individuals with a family history of hematological disorders.
- Patients undergoing evaluation for unexplained blood abnormalities.
- Those with risk factors such as exposure to certain chemicals or previous cancer treatments.
Benefits of Taking the Test
Taking the CBFB-MYH11 Inv(16) Qualitative test offers several benefits:
- Early detection of genetic abnormalities can lead to timely intervention and improved treatment outcomes.
- Helps in determining the prognosis for patients diagnosed with AML.
- Guides healthcare providers in choosing the most effective treatment options.
- Provides peace of mind to patients and their families through accurate diagnosis.
Understanding Your Results
Results from the CBFB-MYH11 Inv(16) Qualitative test will indicate whether the fusion gene is present. A positive result suggests the need for further evaluation and potential treatment options, while a negative result may provide reassurance. It is essential to discuss your results with your healthcare provider to understand their implications fully.
Test Details
| Test Name | Price (NGN) |
|---|---|
| CBFB-MYH11 Inv(16) Qualitative | Regular Price: 120,000 NGN Discount Price: 90,000 NGN |
Booking the Test
To book the CBFB-MYH11 Inv(16) Qualitative test, please contact us at +2348077798758 or visit our website. Remember, a doctor’s prescription is required for this test, except for cases involving surgery, pregnancy, or travel abroad.
Turnaround time for results is typically 3-4 days, and samples can be collected from either bone marrow or peripheral blood. Ensure the sample is transported immediately for accurate results.
